Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F4C1D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,062
Award facts
- Contract value 100% obligated
- $66,061.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $66,061.67 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on November 20, 2025, with completion anticipated by November 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is executed from the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's consistent success in competitively awarded contracts with the DLA across multiple therapeutic domains demonstrates its capability to meet federal procurement requirements for military medical supply needs. This specific delivery order for Dupixent, a biologic immunosuppressant treatment, represents one of numerous pharmaceutical product deliveries the company fulfills under its prime indefinite delivery contract with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F4C1D?
SPE2DR26F4C1D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F4C1D worth?
The government has obligated $66,062 on SPE2DR26F4C1D.
Is contract SPE2DR26F4C1D an order under another contract?
Yes. SPE2DR26F4C1D is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4C1D competed?
The extent of competition for SPE2DR26F4C1D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award